“…Hypoxia increases ROS production, regulates TGF-β, and promotes collagen formation, thereby reducing alveolar elasticity [ 20 ]. In addition, ROS can cause cell loss, alveolar wall edema, increased vascular permeability, and protein exudation, further reducing lung elasticity, destroying vascular integrity, and increasing the apoptosis of alveolar type I epithelial cells, thereby promoting alveolar type II epithelial cell proliferation and aggravating lung inflammation [ 10 , 21 ]. Under long-term cytokine action, fibroblast recruitment and myofibroblast proliferation lead to the remodeling of the extracellular matrix (ECM) and epithelial-mesenchymal transition (EMT), resulting in fibrogenesis and scar formation, eventually replacing the normal lung tissue with the development of advanced PF [ 22 , 23 ].…”